Anti-HSD17B3 antibody,Abcam,AB126228
Host
Rabbit
Reactivity
Human, Mouse, Rat
Application
IHC-P, WB
Platform ID
BAB906110589

Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Specifications
Scientific Background
Target data Catalyzes the conversion of 17-oxosteroids to 17beta-hydroxysteroids (PubMed : 16216911, PubMed : 26545797, PubMed : 27927697, PubMed : 8075637). Favors the reduction of androstenedione to testosterone (PubMed : 16216911, PubMed : 26545797, PubMed : 27927697). Testosterone is the key androgen driving male development and function (PubMed : 8075637). Uses NADPH while the two other EDH17B enzymes use NADH (PubMed : 16216911, PubMed : 26545797, PubMed : 8075637). Androgens such as epiandrosterone, dehydroepiandrosterone, androsterone and androstanedione are accepted as substrates and reduced at C-17 (PubMed : 16216911). Can reduce 11-ketoandrostenedione as well as 11beta-hydroxyandrostenedione at C-17 to the respective testosterone forms (PubMed : 16216911, PubMed : 27927697). See full target information HSD17B3
Category Paths
- Products>Primary Antibodies>Polyclonal Antibodies
- Products>Primary Antibodies>IHC Antibodies
Please provide the required information below so that we can quickly source your products.
